Company / Operating Cash Flow per Share
TransMedics Group, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$5.74
FY2025
5-year range
-$1.65 / $5.74
FY2021-FY2025
Trend
+284.0%
vs FY2024
Sector context
#45 of 155
Health Care
What the data says
Operating Cash Flow per Share changed +284% YoY in FY2025, a notable deviation from the 7-year average annual change of +127%.
Based on SEC 10-K filings.
5.74 in FY2025.
Improved from $-0.41 to $5.74 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#45 of 155 in Health CareTop 29% of 155This company $5.74 Sector average $6.77
▼
-15.3% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 284.0% year-over-year.
- Ranks #45 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.74 | +284.0% |
| FY2024 | $1.49 | +468.5% |
| FY2023 | -$0.41 | +75.4% |
| FY2022 | -$1.65 | -55.2% |
| FY2021 | -$1.06 | +50.1% |
| FY2020 | -$2.13 | +91.2% |
| FY2019 | -$24.16 | -24.3% |
| FY2018 | -$19.44 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026